ELRANATAMAB vs ELTROMBOPAG OLAMINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ELRANATAMAB vs ELTROMBOPAG OLAMINE: Safety Overview
| Metric | ELRANATAMAB | ELTROMBOPAG OLAMINE |
|---|---|---|
| Total FAERS Reports | 758 | 16,074 |
| Deaths Reported | 177 | 3,457 |
| Death Rate | 23.4% | 21.5% |
| Hospitalizations | 482 | 3,284 |
| Average Patient Age | 67.6 yrs | 56.5 yrs |
| % Female Patients | 45.2% | 57.7% |
| FDA Approval Date | N/A | Apr 18, 2024 |
| Manufacturer | Pfizer Laboratories Div Pfizer Inc | XLCare Pharmaceuticals Inc. |
| Route | SUBCUTANEOUS | ORAL |
| Marketing Status | Prescription | Prescription |